Delivery Order SPE2DB24D8003-SPE2DB25FJTZV
Award Date
3/17/25
Potential Completion Date
3/18/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide DIOVAN HCT 160-25 MG TABLET 90S. The contract, valued at $3,570.23, has an ultimate completion date of October 24, 2024 and is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to deliver a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,663.14, is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of May 13, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQKB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,886.34, is for the delivery of Diovan HCT 160-25 mg tablets to support the DLA's Troop Support Medical division. This is a firm-fixed-price delivery order contract with a completion date of February 7, 2024. Dakota Drug, Inc. has also been awarded a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Losartan-HCTZ 100-25 mg tablets. The contract has a ceiling value of $1,747.92 and a completion date of February 11, 2025. The contract is a firm fixed-price delivery order, which is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has a firm fixed price of $22,937.69 and a period of performance through March 5, 2025. This award is not designated as a set-aside contract. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTJJ, was issued by the Defense Logistics Agency (DLA) for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The $2,777.68 fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, on November 26, 2024, with a completion date of November 27, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant $999,999,999.00...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7C2J, was made by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,268.40 firm fixed-price delivery order is for the supply of MICARDIS 40 MG TABLET UD 30S, a pharmaceutical product, with a period of performance extending until January 4, 2024. Dakota Drug, Inc. is a key supplier for the DLA, holding a significant single-award Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business. The contract, valued at $3,900.47, is for the delivery of Jardiance 10 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical products, including prescription medications such as insulin pens, inhalers, anticoagulants, and biologic drugs. The contract, valued at $11,449.29, has an ultimate completion date of September 4, 2024 and is not designated as a set-aside contract. Dakota Drug, Inc. holds a...